THE NAVITOCLAX DIARIES

Experimentally, navitoclax kills cells inside a BAX/BAK-dependent fashion and results in regression of lymphoid tumors in xenograft models.(Sorvall Legend RT; Thermo Fisher Scientific) for 30 min. The ensuing tissue pellet was useful for complete covalent binding Investigation. The ensuing cloudy supernatant was used to find out tissue metabolites